CLINICAL_TRIALS
research
· 2026-01-06
Clinical Trial Update: A Registry: Siltartoxatug Injection for Tetanus Prophylaxis Following Injury
Summary
A registry entry describing a clinical trial evaluating Siltartoxatug Injection for tetanus prophylaxis after injury, which is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd. | Conditions: Tetanus | Status: RECRUITING